OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 9.6 USD -1.13% Market Closed
Market Cap: 97.2m USD

Operating Margin
OptiNose Inc

-20.9%
Current
-53%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-20.9%
=
Operating Profit
-16.3m
/
Revenue
78.2m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
OptiNose Inc
NASDAQ:OPTN
96.6m USD
-21%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
499.3B USD
27%
CH
Roche Holding AG
SIX:ROG
270.5B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
220.3B GBP
24%
US
Merck & Co Inc
NYSE:MRK
270.1B USD
38%
CH
Novartis AG
SIX:NOVN
218.4B CHF
33%
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
143.7B USD
29%
No Stocks Found

OptiNose Inc
Glance View

Market Cap
96.6m USD
Industry
Pharmaceuticals

OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 189 full-time employees. The company went IPO on 2017-10-13. The firm's first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 micrograms (mcg), is a therapeutic utilizing the Company's Exhalation Delivery System (EDS), which delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps. The Onzetra Xsail is a sumatriptan nasal powder and sells in the United States, Canada and Mexico.

OPTN Intrinsic Value
13.43 USD
Undervaluation 29%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-20.9%
=
Operating Profit
-16.3m
/
Revenue
78.2m
What is the Operating Margin of OptiNose Inc?

Based on OptiNose Inc's most recent financial statements, the company has Operating Margin of -20.9%.

Back to Top